135
Views
0
CrossRef citations to date
0
Altmetric
News

Oral drug sets new survival standard for bone marrow cancer: Abramson Cancer Center participates in landmark Phase III study for myeloma treatment

Page 1831 | Published online: 01 Dec 2007

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.